Liver disease, a significant health concern, progresses from potentially reversible fibrosis to irreversible cirrhosis. While early fibrosis often shows no symptoms, cirrhosis brings debilitating ...

The addition of SGLT2 inhibitors was associated with a nearly one third lower incidence of serious liver events in individuals with cirrhosis who were receiving diuretic therapy, a large cohort study ...

The primary combined endpoint occurred in 26.8% of patients in the rivaroxaban group vs 46.9% of those in the placebo group, with 1-year survival probabilities of 78.7% vs 54.4% and 2-year survival ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Use of sodium-glucose cotransporter 2 inhibitors was ...

Having rolled out from Sorosis Park, up on a bluff above The Dalles and the Columbia River, 20 minutes earlier, I was pedaling uphill on a lonely, winding paved road through sprawling cherry orchards.

On Wednesday, Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) reported two-year results from the open-label compensated MASH cirrhosis (F4c) arm of the Phase 3 MAESTRO-NAFLD-1 trial of Rezdiffra ...

SGLT-2 inhibitors, compared with DPP-4 inhibitors, were associated with a lower risk for liver cirrhosis among patients with type 2 diabetes. Sodium-glucose cotransporter 2 (SGLT-2) inhibitors, ...

Researchers describe successful tumor removal through the use of immunotherapy and targeted radiation therapy (TARE), in a patient previously considered ineligible for the procedure. The risk of ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Does Fatty Liver Lead to Cirrhosis ? Fatty liver disease, now called steatotic liver disease, happens when too much fat builds up in your liver. Over time, this extra fat can cause inflammation and ...

Sarcopenia is a common complication of decompensated cirrhosis resulting in progressive loss of muscle mass and function. The Food and Drug Administration (FDA) has granted Fast Track designation to ...